Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

FDA Approves the Influenza Vaccine Formulation for the 2011-2012 Flu Season.

Regulatory Roundup: FDA Approves the Influenza Vaccine Formulation for the 2011-2012 Flu Season

Amy Ritter was Scientific Editor, BioPharm International.

A bill introduced by Senators Scott Brown (R-MA), Ron Wyden (D-OR), and John McCain (R-AZ) on July 13, 2011, aims to encourage states to reduce Medicaid spending by offering financial incentives to substitute generic drugs for branded ones where possible.

Bipartisan Bill Introduced to Encourage Generic Drug Use in Medicaid

The performance of biotechnology venture capital and investment is lackluster at best.

Biotech Financing Blues

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The solid form of an API plays a crucial role in drug quality, and advancing methods for screening, detection, and characterization is key.

In Search of an Optimal Solid Form

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.

FDA and Manufacturers Ponder Biosimilars Pathway

A technical leader in solid dosage forms Pfizer CentreSource provides analytical, technical, regulatory, developmental, manufacturing and packaging support that spans the specialized realm of highly potent solid oral dose drug products.

Broad Range of Highly Potent Finished Dosage Form Contract Manufacturing Capabilities from Pfizer CentreSource Speaks to Outsourcing Demand

Merck and Hanwha Chemical have formed an exclusive global agreement to develop and a commercialize a biosimilar of Enbrel, a drug to treat moderate to severe plaque psoriasis, psoriatic arthritis, and moderate to severe rheumatoid arthritis.

Merck to Develop Biosimilar with Korean Chemical Manufacturer

Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.

Optimising High-Potency Manufacture

More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.

Next-Gen Expression Systems

Academic–industry partnerships are increasingly important in biopharmaceutical innovation.